Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Streetwise Reports
$46.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Glaxosmithkline Plc Issues FY 2013 Guidance Above Analysts' Estimates-Conference Call


Wednesday, 6 Feb 2013 02:00pm EST 

Glaxosmithkline Plc announced that for fiscal 2013, it sees sales guidance of 1%, earnings per share guidance of 3% to 4%. The Company reported revenue of $42.025 billion and EPS of $3.53 in fiscal 2012. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $42.012 billion, and EPS of $2.97 for fiscal 2013.